JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 3 435-437
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cleto, E. M.
Right arrow Articles by Hoffman, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleto, E. M., Jr.
Right arrow Articles by Hoffman, T. J.

Radiographic and Neuro-SPECT Imaging in an Immature Third Ventricle Teratoma: Case Report

Emmanuel M. Cleto, Jr., Richard A. Holmes, Amolak Singh, Robin Bierman, Saiful Islam and Timothy J. Hoffman

Department of Radiology/Nuclear Medicine, University of Missouri Hospital and Clinics, Columbia, Missouri
Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri

Correspondence: For reprints contact: Emmanuel M. Cleto, Jr., MD, Department of Radiology/Nuclear Medicine, University of Missouri Hospital and Clinics, One Hospital Drive, Columbia, MO 65212.

ABSTRACT

We report a case of an immature teratoma of the third ventricle, which was preoperatively thought to be a choroid plexus papilloma. The diagnosis was made by biopsy since the radiographic (CT, MRI), angiographic and scintigraphic findings ([99mTc]pertechnetate, 99mTc-DTPA, 99mTc-HMPAO brain SPECT) were nonspecific. Disruption of the blood-brain barrier is the mechanism for radionuclidic and contrast tumoral uptake and is demonstrated by marked contrast enhancement on CT and focal concentration on [99mTc]pertechnetate and 99mTc-DTPA images. No suppression of [99mTc]pertechnetate tumor uptake was observed following the administration of potassium perchlorate. Increased concentration of tumor protein is suggested by the increased signal on the T1-weighted magnetic resonance images and high [99mTc]pertechnetate uptake. The tumor's detection on the 99mTc-HMPA brain SPECT was due to its intraventricular location. A number of potential mechanisms for brain tumor localization of 99mTc-HMPAO are discussed.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
J. Wolff
Perchlorate and the Thyroid Gland
Pharmacol. Rev., March 1, 1998; 50(1): 89 - 106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.